How much funding has Frontier Medicines raised?

Frontier Medicines has raised $255.5M in total funding, most recently a Extension Round.

Who are Frontier Medicines's investors?

Frontier Medicines's investors include Droia Ventures, Deerfield Management, Galapagos NV, Sphera Funds Management.

When was Frontier Medicines founded?

Frontier Medicines was founded in 2019.

Where is Frontier Medicines headquartered?

Frontier Medicines is headquartered in San Francisco, California, United States.

What industry is Frontier Medicines in?

Frontier Medicines operates in Biotech, Drug Discovery, Life Sciences.

How many employees does Frontier Medicines have?

Frontier Medicines has 51-200 employees.

Frontier Medicines

Pioneers in boldly advancing science

San Francisco, United States · Founded 2019 · $255.5M raised

Biotech

Drug Discovery

Life Sciences

Headquarters: San Francisco, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: frontiermedicines.com
Total Funding: $255.5M
Last Round: $20.0M Extension RoundJun 2024
Rounds: 4

About

Frontier Medicines is a clinical-stage precision medicine company pioneering covalent small-molecule drug discovery against previously undruggable targets. Its Frontier Platform combines chemoproteomics with machine learning to identify novel covalent binding sites across the proteome. The company has advanced multiple oncology development candidates and holds partnerships with major biopharma companies including AbbVie.

Summary

Frontier Medicines is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $255.5M in total across 4 rounds, most recently a $20.0M Extension Round round in Jun 2024. Investors include Droia Ventures, Deerfield Management and Galapagos NV.

LinkedIn X (Twitter)